MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-09-2023
Applied Molecular Transport ROE Ratio 2011-2026 | AMTI
Annual ROE Ratio Applied Molecular Transport
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -207.64 | -61.3 | -50.55 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -50.55 | -207.64 | -106.5 |
Quarterly ROE Ratio Applied Molecular Transport
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -236.06 | -225.5 | -178.32 | -102.23 | -116.09 | -97.8 | -72.38 | -43.24 | -55.99 | -54.88 | -55.21 | -36.06 | -25.09 | -1.37 | 20.5 | 31.35 | 31.35 | 20.38 | 10.19 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 31.35 | -236.06 | -62.44 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aligos Therapeutics
ALGS
|
-45.18 | $ 7.92 | -0.94 % | $ 78.3 M |  USA |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.63 | -2.42 % | $ 8.73 B |  Australia |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M |  China |
 |
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | France |
 |
Applied Therapeutics
APLT
|
698.49 | - | - | $ 8.42 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Precision BioSciences
DTIL
|
-325.11 | $ 6.73 | 0.9 % | $ 25.9 M | USA |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Esperion Therapeutics
ESPR
|
7.51 | $ 2.15 | -0.69 % | $ 447 M | USA |
 |
Evogene Ltd.
EVGN
|
-41.09 | $ 0.81 | -0.33 % | $ 27.9 M |  Israel |
 |
BioNTech SE
BNTX
|
1.11 | $ 97.86 | 2.47 % | $ 27.2 B | Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
12.44 | $ 20.29 | -0.39 % | $ 948 M | USA |
 |
Galectin Therapeutics
GALT
|
24.11 | $ 2.42 | 5.22 % | $ 155 M | USA |
 |
Genmab A/S
GMAB
|
24.88 | $ 28.24 | -0.04 % | $ 18 B |  Danmark |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | USA |
 |
Grifols, S.A.
GRFS
|
9.2 | $ 8.14 | -0.85 % | $ 6.83 B |  Spain |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
GT Biopharma
GTBP
|
-489.96 | $ 0.36 | -3.5 % | $ 1.98 M | USA |
 |
Halozyme Therapeutics
HALO
|
649.18 | $ 67.79 | -0.05 % | $ 8.12 B | USA |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
-16.39 | $ 1.42 | 1.07 % | $ 365 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
Allakos
ALLK
|
-110.0 | - | - | $ 28.6 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 2.96 | 1.37 % | $ 4.87 M | Israel |
 |
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | USA |
 |
Aquestive Therapeutics
AQST
|
248.9 | $ 4.15 | 1.72 % | $ 444 M | USA |
 |
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 24.3 | 0.37 % | $ 3.09 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
18.24 | $ 28.82 | -0.24 % | $ 1.66 B | USA |
 |
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | USA |
 |
Celldex Therapeutics
CLDX
|
-49.08 | $ 32.37 | 0.4 % | $ 2.15 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.52 | 1.68 % | $ 405 M | Britain |
 |
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | Canada |
 |
Cidara Therapeutics
CDTX
|
-103.99 | - | - | $ 1.41 B | USA |
 |
ImmuCell Corporation
ICCC
|
-3.84 | $ 7.24 | 2.33 % | $ 65.3 M | USA |
 |
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | USA |
|
Immatics N.V.
IMTX
|
1.79 | $ 10.61 | 1.73 % | $ 668 M | Germany |
 |
Incyte Corporation
INCY
|
24.9 | $ 96.66 | 0.61 % | $ 18.9 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-71.51 | $ 2.58 | 1.18 % | $ 16.2 M | USA |
 |
InflaRx N.V.
IFRX
|
-43.64 | $ 1.05 | 4.95 % | $ 152 M | Germany |